CVRX - CVRx Inc

https://www.cvrx.com

Hold Momentum: Bearish

Recent News

CVRx ( CVRX ) Reports Q2 Loss, Beats Revenue Estimates

Zacks Commentary • 1 month, 1 week ago • score: 0.08

CVRx (CVRX) delivered earnings and revenue surprises of -9.62% and +0.96%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Bullish

CVRx to Present at the Canaccord Genuity 45th Annual Growth Conference

GlobeNewswire • 1 month, 2 weeks ago • score: 0.40

MINNEAPOLIS, July 29, 2025 ( GLOBE NEWSWIRE ) -- CVRx, Inc. ( NASDAQ: CVRX ) ( "CVRx" ) , a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that the ...

Bullish

CVRx to Present at the Canaccord Genuity 45th Annual Growth Conference - CVRx ( NASDAQ:CVRX )

Benzinga • 1 month, 2 weeks ago • score: 0.36

MINNEAPOLIS, July 29, 2025 ( GLOBE NEWSWIRE ) -- CVRx, Inc.

Bullish

CVRx to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call on August 4, 2025

GlobeNewswire • 1 month, 3 weeks ago • score: 0.34

MINNEAPOLIS, July 21, 2025 ( GLOBE NEWSWIRE ) -- CVRx, Inc. ( NASDAQ: CVRX ) ( "CVRx" ) , a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that it ...

Bullish

CVRx ( CVRX ) Surges 19.0%: Is This an Indication of Further Gains?

Zacks Commentary • 1 month, 4 weeks ago • score: 0.36

CVRx (CVRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Bullish

CVRx Announces Positive News on Outpatient Payment for Barostim

Benzinga • 1 month, 4 weeks ago • score: 0.26

MINNEAPOLIS, July 16, 2025 ( GLOBE NEWSWIRE ) -- CVRx, Inc.

Bullish

CVRx Announces Positive News on Outpatient Payment for Barostim

GlobeNewswire • 1 month, 4 weeks ago • score: 0.25

MINNEAPOLIS, July 16, 2025 ( GLOBE NEWSWIRE ) -- CVRx, Inc. ( NASDAQ: CVRX ) ( "CVRx" ) , a commercial-stage medical device company, announced today that the Centers for Medicare and Medicaid Services ( CMS ) has proposed to keep the Barostim implant procedure as part of the New Technology ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Range-Bound

As of 2025-09-09 (Snapshot)

CVRx, Inc. develops implantable technology for the treatment of patients with high blood pressure / hypertension and heart failure.

52W High

$18.55

52W Low

$4.30

MA Status:

50D: Above 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.22

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-1.31

EV/Revenue (<3 favorable)

2.92

P/S (TTM) (<3 favorable)

3.74

P/B (<3 favorable)

3.52

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

4.31%

Institutions (25–75% balanced)

67.87%

Shares Outstanding

26,072,600

Float

17,964,100

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

54,652,000

Gross Profit (TTM)

45,658,000

EPS (TTM)

-2.06

Profit Margin (>10% good)

-0.96%

Operating Margin (TTM) (higher better)

-1.06%

ROE (TTM) (>15% strong)

-0.92%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

0.15

Momentum

Bearish momentum

Value

0.1841

0.2013

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025